Navigation Links
Oxygen Orchard Featured in SkyMall Magazine and Estimates $80,000,000 in Net Profit from 0.5% Market Penetration

ORCHARD, Texas, Aug. 11, 2011 /PRNewswire/ -- Oxygen Orchard (Pinksheets: GTLL) announced today its internal estimates on market penetration and expected profits should the Company's estimates prove accurate.

The Company believes the domestic wellness market is almost limitless.  According to a National Institutes of Health study, in 2009, 88 million American adults used some form of Complementary and Alternative Medicine.

The Company believes a conservative market share estimate is one half of 1% of those 88 million people.  If those 440,000 people purchased The Big Pitcher, the net profit for Oxygen Orchard, Inc. will be $80,000,000.  This is just one of the Company's target markets for its innovative and patented products.

Oxygen Orchard is poised to pursue rapid penetration in not only the domestic markets but also international. Oxygen Orchard is the only manufacturer of The Big Pitcher and its family of products, with a ten-year track record and proven history of order fulfillment.  The Company notes continuously increasing interest in its products not only in the USA, but worldwide.

On the domestic side, having been featured in SkyMall Magazine for four years, by invitation, Oxygen Orchard, Inc. has reached into many households.  The unparalleled exposure is certainly partially responsible for increased awareness of the importance of supplemental oxygen.  The Company believes its products are superior to competitors in both price and quality.  As a result, the Company makes and sells America's #1 water oxygenating machines.

About Oxygen Orchard, Inc.

Oxygen Orchard, Inc. specializes in the design, manufacture and sale of its patented water oxygenating system. The Company is the industry leader in its product category. Based on medical research and market results, the Company's products provide supplemental oxygen to users, resulting in ailment prevention and enhancement of overall wellness. Oxygen Orchard is a woman-owned business and is currently expanding its operations and product distribution internationally.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the Safe Harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from the expected results.

Oxygen Orchard, Inc.
P.O. Drawer A
Orchard, TX 77464
Toll Free: 877-347-7770

SOURCE Oxygen Orchard, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dehaier Opens First Oxygen Filling Facility and First Service Center for Home Oxygen Therapy Service in Beijing
2. Global Technologies, Ltd. Announces LOI to Acquire and Merge with Oxygen Orchard, Inc.
3. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
4. Masimo Launches New Reusable SpCO® Sensor with Improved Accuracy and Reliability in Low Oxygen Saturation and Elevated Methemoglobin States
5. Global Medical Oxygen Systems Industry
6. Reportlinker Adds Global Medical Oxygen Systems Industry
7. Facelift Healing Innovation: New Study Shows Hyperbaric Oxygen Therapy Decreases Bruising in Facelifts Patients by 35%
8. ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device
9. Supplemental Oxygen Company Offers Steps to Improve COPD Patients Lives
10. CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation
11. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
Post Your Comments:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):